Hint mode is switched on Switch off

Werewolf Therapeutics, ordinary share
HOWL, US95075A1079

Add a stock to WL
Choose all Reset all
Werewolf Therapeutics, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

Profile
Werewolf Therapeutics, Inc. operates as an oncology biotherapeutics company. The Company develops novel immuno-stimulatory therapeutics and medicines for the treatment of cancer diseases. Werewolf Therapeutics in the State of Massachusetts.
  • Issuer
  • Full borrower / issuer name
    Werewolf Therapeutics, Inc.
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    HOWL
  • Placement
    30.04.2021
  • Lock up period
    180
  • Number of papers
    7,500,000
  • Volume of raised funds
    120 mln USD
  • Placement share
    27.23%
  • Final placement price
    16 USD
  • Price change since placement date
    -97.36%
  • By capitalization
    440.63 mln USD

IFRS/US GAAP reports

2025
I q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
Show all Hide

Related Stock indices

Indicators

News

09/02/2026 Werewolf Therapeutics: Costs Associated With Exit Or Disposal Activities, Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Regulation Fd
18/12/2025 Werewolf Therapeutics: Other Events, Financial Statements And Exhibits
12/06/2025 Werewolf Therapeutics: Amendments To Articles Of Incorporation Or Bylaws; Change In Fiscal Year, Submission Of Matters To A Vote Of Security Holders, Financial Statements And Exhibits
13/05/2025 Werewolf Therapeutics: Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of Listing
08/05/2025 Werewolf Therapeutics: Results Of Operations And Financial Condition, Regulation Fd Disclosure, Financial Statements And Exhibits
All organization news

Holders

Industry Leaders

Registration is required to get access.